Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism

Autor:	Richard Bedlack, Paul Mehta, James D. Berry, Moon Kwon Han, Hiroshi Mitsumoto, Sabrina Paganoni, Jaime Raymond, Theodore C. Larson, Kevin Horton
Rok vydání:	2021
Předmět:	Oncology Adult National ALS Registry medicine.medical_specialty amyotrophic lateral sclerosis Adolescent Health Informatics research notification mechanism Young Adult Lou Gehrig disease Internal medicine Epidemiology medicine Humans Registries Aged patient recruitment Clinical Trials as Topic Original Paper clinical trials business.industry Mechanism (biology) Patient Selection ALS - Amyotrophic lateral sclerosis Middle Aged humanities Clinical trial Patient recruitment Epidemiologic Studies Research Design motor neuron disease business
Zdroj:	Journal of Medical Internet Research
ISSN:	1438-8871
Popis:	Background Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible. Objective The aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry’s (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies. Methods Through the Registry’s online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study’s specific eligibility criteria, and then distributes the researcher’s study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees. Results From 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%). Conclusions The National ALS Registry’s RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be66c3f1a0bfc7832198d61d8673c81d https://pubmed.ncbi.nlm.nih.gov/34878988 Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.